SurExam Bio-Tech Co., Ltd. provides personalized medical system solutions focused on tumor molecular diagnostic products and clinical medicine testing services. Its products include medical kits, as well as it provides medical testing services. The company was founded on November 28, 2006 and is headquartered in Guangzhou, China.

Huachuang Good Agriculture Biotechnology (Wuhan) Co., Ltd., established on 2019-01-22, Business scope includes technology development in the field of biotechnology,technical consulting,technology transfer;fertilizer,laboratory reagent(Free of Hazardous Chemicals)and consumables,pesticide,Technical consultation on soil remediation agents,technology development,Production(Limited to branch operations),Sales.(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, established on 2006-06-27, Business scope includes

Part of Zoetis, Inc., Zoetis Services LLC is a company headquartered in Florham Park, NJ, that discovers, develops, manufactures and sells animal health medicines and vaccines.

Tianjin Zhongao Animal Husbandry Co., Ltd., established on 2003-01-30, The business scope includes the development of sheep breeding technology,consultation service,transfer.(If the above business scope involves pre-licensing, it shall not engage in business activities before obtaining or exceeding the valid period,If the country has special management regulations, it shall be handled according to the regulations)

Shuwen Biotechnology (Xuancheng) Co., Ltd., established on 2017-10-16, Business scope includes biological reagents,biomedicine,Biomedical equipment and equipment,Technology research and development of computer software,technology development,technology transfer,Technical Advisory Services,biological reagent(Except for licensed items such as medical devices),scientific research instrument,Healthy food(except vegetable oil),medical instruments(Limited to obtain<Medical Device Business License>s project),Wholesale of fitness equipment and import and export of goods and technology,second,Three categories6840Production and sales of in vitro diagnostic reagents(Country Restricted,Except for prohibited foreign investment projects).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Chest Hospital is a Chinese company ultimately controlled by the Government of China. The firm specializes in treating cadio-vascular system, lungs, esophagus, trachea and mediastinum.

Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and the largest sequencing capacity in the world. Novogene utilizes scientific excellence, a commitment to customer service and unsurpassed data quality to help their clients realize their research goals in the rapidly evolving world of genomics. The company has become a world-leader in NGS services, with 1,800 employees and multiple locations across the globe. Novogene’s depth of experience has resulted in the ownership of 49 NGS-related patents, as well as the publishing of over 1850 customer research papers, often in well-respected publications such as Nature and Science. Company founder, Dr. Ruiqiang Li, is widely recognized as one of the world’s leading experts in genomics and bioinformatics, owning 12 patents and authoring over 90 peer-reviewed publications that have been cited >15,000 times. Best known for developing the software SOAP (Short Oligonucleotide Analysis Package) for ultra-fast sequence mapping, variation detection, and de novo genome assembly, Dr. Li has focused Novogene’s services on performing sequencing AND providing informatics to fully empower and enable their customers to move forward rapidly and effectively in their scientific endeavors.

Tsingtao Brewery Co., Ltd. engages in the manufacture and sale of beer and related products. It operates through the following business segments: Shandong; South China; North China; East China; Southeast; Hong Kong, Macau, and overseas; and Finance. The Shandong segment engages in the production and sale of beer in Shandong and surrounding areas. The South China, North China, East China, and Southeast segments engage in the production and sale of beer in the respective areas. The Hong Kong, Macau, and overseas segment engages in the sale of beer in Hong Kong, Macau, and overseas. The Finance segment handles the financial management and financial transactions such as payment and collection of member units. The company offer the verities of beer include Great ocean beer, Huiquan beer, Tsingtao draft beer, Tsingtao dark beer, Tsingtao beer premium and Tsingtao beer. Tsingtao Brewery was founded in August 1903 and is headquartered in Qingdao, China.

Cell Signaling Technology, Inc. (CST) is a privately held company that develops and produces antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents used to study the cell signaling pathways that impact human health. CST maintains an in-house research program, particularly in the area of cancer research, and has published scientific papers in many peer-reviewed journals.

Forschungszentrum Jülich ("Jülich Research Centre") is a member of the Helmholtz Association of German Research Centres and is one of the largest interdisciplinary research centres in Europe. It was founded on 11 December 1956 by the state of North Rhine-Westphalia as a registered association, before it became "Kernforschungsanlage Jülich GmbH" or Nuclear Research Centre Jülich in 1967. In 1990, the name of the association was changed to "Forschungszentrum Jülich GmbH". It has close collaborations with RWTH Aachen in the form of Jülich-Aachen Research Alliance (JARA).

Guangxi Nanning Duobo Biotechnology Co., Ltd., established on 2022-04-12, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Extraction of marine bioactive substances,purification,Synthesis technology research and development;Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;Research and development of bio-based materials technology;Research and development of biopesticide technology;internet sales(Except for products that require a license for sale);Sales of Class I Medical Devices;Sales of Class II Medical Devices;Sales of hygiene products and single-use medical products;Specialty Chemicals Sales(Free of Hazardous Chemicals);Sales of plastic products(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Shanghai Beilian Biotechnology Co., Ltd., established on 1998-09-16, The scope of business includes engaging in biotechnology(except food,medicine,blood products)technology development in the field,technology transfer,technical consulting,Technical Services,Agricultural product acquisition(Except for special regulations:cotton,food),Engaged in the import and export of goods and technology,Food Additive Sales,Food additive production(Those who have not obtained a food additive production license,Do not engage in the production of food additives),Own Equipment Rental(Not to engage in financial leasing),Wholesale of machinery and equipment,retail,Own house rental,Food Machinery Design,manufacture,wholesale,retail,Warehousing Services(Removal of hazardous chemicals),food circulation. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

NEC Corp. engages in the provision of systems, components, services, and integrated solutions for computing and communications applications. It operates through the following segments: Public Business, Enterprise Business, Telecom Carrier Business, System Platform Business, and Others. The Public Business segment provides system integration (system architecture and consulting), support (maintenance), outsourcing and cloud services, and system equipment for public, medical and financial institutions. The Enterprise Business segment offers information technology solutions for manufacturing, retail, and services. The Telecom Carrier Business segment supplies equipment to telecom carriers for network implementation, along with network control platform systems and operating services. The System Platform Business deals with products from business such as from terminals to network and computer equipment, software products, and service platforms. The Others segment includes smart energy solutions, mobile phones, and lighting equipment businesses. The company was founded by Kunihiko Iwadare on July 17, 1899 and is headquartered in Tokyo, Japan.

Takara Bio Inc., develops, manufactures, and distributes a wide range of life science reagents and kits under the Takara®, Clontech®, and Cellartis® brands. Key products include SMART® cDNA synthesis kits for a variety of samples and applications, including NGS; high-performance qPCR and PCR reagents (including the Takara Ex Taq®, Takara LA Taq®, Titanium®, and Advantage® enzymes); Cellartis stem cells and stem cell reagents; RT enzymes and SMART library construction kits; the innovative In-Fusion® cloning system; Guide-it™ gene editing tools; Tet-based inducible gene expression systems; and Living Colors® fluorescent proteins. These and other products support applications including NGS; gene discovery, regulation, and function studies; protein expression and purification; RNAi, gene editing, and stem cell studies; and plant and food research

Maccura Biotechnology Co., Ltd. was incorporated in 1994. It focuses on In-Vitro Diagnostic reagents’ development, manufacture, marketing and service. Maccura is an IVD integration company of research & development, production, sales and services. Maccura has the best research & development team around the world which is led by several scientists. Maccura has established five product and technology development platforms which cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis. We become the first enterprise member at IFCC. As an IVD company, Maccura is the first batch to build the enzymatic reference laboratory, and traceable results of maccura’s diagnostic products have reached the international advanced level.

Beijing Huaqing Chuangxiang Education Technology Co., Ltd., established on 2019-10-11, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;software development;literary creation;Application software service;Computer System Services;data processing(Bank Card Center in Data Processing,PUEvalue in1.4Except for the above cloud computing data centers);business management;market survey;Economic and Trade Consulting;Business Management Consulting;public relations service;buisness planning,design;design,make,acting,Place an ad;Basic software service;computer animation design;translation service;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Agricultural Science Research and Experimental Development;Medical Research and Experimental Development;Undertake exhibition and display activities;software consulting;product design;model design;Packaging and decoration design;Cultural Consulting;Conference Services;arts and crafts design;Organize cultural and artistic exchange activities(Does not include commercial performances);Television planning;Sell ​​self-developed products;Educational Consulting(Except for intermediary services);Sports Advice;health management(Except for medical treatment activities subject to approval);Health Advisory(Except for medical treatment activities subject to approval).(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.).